Join Thomas Bird, an expert in human germline editing, and John Hardy, a groundbreaking researcher in Alzheimer’s genetics, as they dive into the fascinating world of neurogenetics. They discuss the latest advancements in sequencing technologies, the complexities of deciphering genetic inheritance in neurological conditions, and the ethical implications of CRISPR technology. Hardy shares insights from his research on Alzheimer's genes, while Bird emphasizes the urgent need for improved genetic counseling. Together, they navigate the future of genetic research and its transformative impact on healthcare.
